SAN DIEGO, Calif., May 21, 2012 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a worldwide leader in precision guided therapy tools, today provided an overview of data from multiple ground-breaking

SAN DIEGO, May 14, 2012 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC) today announced its plans to highlight its extensive product portfolio, strong product pipeline, and presentations

ABBOTT PARK, Ill. and ST. PAUL, Minn., April 23, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) and St.

A meta-analysis of eight previously published clinical trials suggests that initial stent implantation for patients with stable coronary artery disease is not associated with improved outcomes compared with initial medical therapy for prevention of death, nonfatal heart attacks, unplanned revascularization or angina.

http://jpmorgan.metameetings.com/webcasts/healthcare12/directlink?ticker=VOLC and via the company's website at www.volcanocorp.com.